Ligand - independent and tissue - selective
androgen receptor inhibition by pyrvinium.
Not exact matches
The new research found that on top of their known effects on cancer, Hsp90
inhibition also blocked production of abnormal forms of the
androgen receptor, stripping cancer cells of their defences against hormone treatments.
Hsp90
inhibition also reduced the levels of the normal
androgen receptor, and other important prostate cancer molecules called AKT and GR.
Inhibition of cell migration and invasion of enzalutamide - resistant prostate cancer cells was effected by niclosamide through its effects on the
androgen receptor (AR)- STAT3 signaling axis [40].